Peter D. Reaven
Papers
1
Total Citations
52
H-Index
1
About
Dr. Peter D. Reaven is a leading researcher in endocrinology and metabolic disorders, with a particular focus on the clinical measurement and role of insulin-like growth factor 1 (IGF1). His major contributions center on advancing the analytical methods for quantifying IGF1, a critical biomarker for managing growth hormone disorders. Dr. Reaven pioneered a groundbreaking parallel workflow for high-throughput mass spectrometric immunoassay, enabling the analysis of over 1,000 samples per day—a transformative leap in clinical diagnostics. This work, published in 2014 and cited 52 times, addresses the growing demand for mass spectrometry-based detection in routine clinical settings, offering enhanced specificity and throughput compared to traditional immunoassays. By tackling the technical challenges of widespread clinical adoption, Dr. Reaven’s research has paved the way for more accurate and efficient monitoring of growth hormone-related conditions. His achievements underscore a commitment to bridging cutting-edge analytical chemistry with practical endocrinology, making him a key figure in the evolution of biomarker quantification and personalized medicine.
Research Focus
Key Achievements
Top Papers
- 1